Lysando AG market leader in the field of antimicrobial proteins has signed a general development agreement with Amicogen Inc., a publicly traded biotechnology company and CDMO headquartered in South
TRIESENBERG, Liechtenstein (BUSINESS WIRE) #Artilysin Lysando AG – market leader in the field of antimicrobial proteins – is pleased to announce that Fabian Geldmacher, M.D., has joined the team as Director Strategy & Business Development in June. Dr. Geldmacher will be responsible for shaping Lysando's strategy.
Lysando AG market leader in the field of antimicrobial proteins is pleased to announce that Wilhelm von Haller has joined the team as Chief Financial Officer this March. Baron von Haller is an expert
TRIESENBERG, Liechtenstein (BUSINESS WIRE) #Artilysin The market-leader for antimicrobial proteins, Lysando AG, has appointed Sang Jung Kim as new member to the Board of Directors. Kim has a strong Biotech background and a proven successful track record of more than 30 years experiences in relevant commercial are.